Invitro announced the suspension of antibody testing

The network of laboratories "Invitro" suspends testing for quantitative antibodies to CORONAVIRUS due to a shortage of reagents. This was reported to RBC in the press service of the company.

In Vitro explained that due to the explosive demand for tests, they were forced to transfer all laboratory complexes to round-the-clock work, they are now purchasing new equipment and introducing additional shifts in laboratories.

“We are indeed experiencing a shortage of reagents, so we are very sorry to announce that we are pausing sales of the quantitative antibody test for seven to 10 days,” the company said.

Now the network of laboratories is waiting for the supply of reagents, after which it intends to resume research in full. During the suspension period, Invitro will offer citizens a new quantitative antibody test based on a different test system. It will be available in limited quantities in the busiest regions: Moscow, St. Petersburg , Novosibirsk, the Urals.